PHOENIX, AZ / ACCESSWIRE / March 4, 2024 / RushNet, Inc (OTC PINK:RSHN), (the “Company”) announced today the appointment of Michael Cunha as its new Chairman and Chief Executive Officer, effective immediately. Mr. Cunha assumes these roles following the resignation of Ashley Sweat, who has decided to explore other opportunities. The Company extends its best wishes to Mr. Sweat for success in his future endeavors and expresses gratitude for his past contributions. It’s important to note that the incoming management team has no prior affiliations with any former management teams of RushNet.
Mr. Cunha, the new Chairman and Chief Executive Officer of Rushnet commented, “I have run very successful private companies in my career, and this is my first experience with a public company. We are immediately transitioning out of the lab business, and we will announce our new business direction within the next few days.”
Mr. Cunha is a distinguished Arizona-based entrepreneur renowned for his track record of establishing thriving enterprises. He attained academic excellence, graduating summa cum laude from Washington State University with a Bachelor of Science in Psychology, and later achieving the same honor at Chapman University, where he earned his MBA in Accounting and Economics.
With an extensive background spanning over three decades in manufacturing, accounting, finance, and executive leadership, Mr. Cunha brings a wealth of experience to the table. Notably, he served as the Corporate Controller of Andermac, Inc., a medical equipment manufacturer, for a duration of eight years. During his tenure, Mr. Cunha spearheaded initiatives that led to the company’s automation, resulting in substantial market expansion. Under his guidance, Andermac achieved a dominant market share of 50% in California and 25% nationwide.
In late 1991, Mr. Cunha embarked on a new venture by co-founding InterMag, Inc., a magnetic media manufacturing company, alongside four partners. Assuming responsibilities in finance and manufacturing, Mr. Cunha played a pivotal role in securing the company’s inaugural contract with Iomega for the production of Iomega 100mb Zip disks. Under his leadership, InterMag experienced remarkable growth, scaling from inception to a revenue of $72 million within a span of three years. In 1995, InterMag was sold to the second largest magnetic media company in Taiwan.
In 1996, Mr. Cunha, alongside two business partners, established what has evolved into Mionix Corporation. Mionix has emerged as a frontrunner in human and animal feed additive antimicrobials, with notable contributions such as the development and promotion of a feed additive aimed at regulating gut bacteria in shrimp, a significant achievement in Southeast Asia. Mionix Corporation underwent a successful acquisition in June 2015. Presently, Mr. Cunha serves as the Managing Member of Patmos Holdings I, LLC, a holding company dedicated to investing in early-stage companies.
About RushNet
With over 25 years in the public sector, RushNet has continually evolved, embracing change and innovation at every turn. The company is completing its transition out of the lab business.
CONTACT:
Michael Cunha
Phone 916-616-7037
Email mcunha53@gmail.com
Twitter Handle: @rushnetrevival
Safe Harbor Notice
Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). The Company cautions that the statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. The Companies undertake no obligation to revise these statements following the date of this news release.
SOURCE: RushNet
View the original press release on accesswire.com
Testing nanotechnology to assess for further optimization of manufacturing process at DunmoreOakville, Ontario--(Newsfile Corp. -…
Proceeds Will Support Completion of Pivotal APOLLOE4 Phase 3 Study Evaluating ALZ-801/Valiltramiprosate and Regulatory Filings…
Led by Cortes Capital, LLC, Sorenson Communications, LLC., SMK (Japan), and Hackensack Meridian Health, Series…
WASHINGTON, June 12, 2024 /PRNewswire/ -- Gallup's latest State of the Global Workplace report finds that…
SAN DIEGO, June 12, 2024 /PRNewswire/ -- Alida Biosciences (AlidaBio), an innovator in epigenomic research tools,…
UPPSALA, Sweden, June 12, 2024 /PRNewswire/ -- ScandiNova Group is proud to announce its participation…